Several potent FTO inhibitors have been demonstrated to suppress the proliferation of cancer cells, such as R-2HG, FB23-2, CS1, CS2, and SsD in leukemia cells [39,101,118,122]; MA2 in GSCs [41]; and MO-I-500 in breast cancer cells [45]. Here, FTO is linked to breast carcinoma.